Drug companies are sitting on generics—43% of recently approved aren’t for sale - Ars Technica

You pay more for medicine because hundreds of generics aren't for sale.....
https://arstechnica.com/science/2019/02/drug-companies-are-sitting-on-generics-43-of-recently-approved-arent-for-sale/